104 related articles for article (PubMed ID: 31250523)
1. Targeted therapy and disease monitoring in CNTRL-FGFR1-driven leukaemia.
Brown LM; Bartolo RC; Davidson NM; Schmidt B; Brooks I; Challis J; Petrovic V; Khuong-Quang DA; Mechinaud F; Khaw SL; Majewski IJ; Oshlack A; Ekert PG
Pediatr Blood Cancer; 2019 Oct; 66(10):e27897. PubMed ID: 31250523
[TBL] [Abstract][Full Text] [Related]
2. Myeloid/lymphoid neoplasm with CEP110-FGFR1 fusion: An analysis of 16 cases show common features and poor prognosis.
Chen M; Wang K; Cai X; Zhang X; Chao H; Chen S; Shen H; Wang Q; Zhang R
Hematology; 2021 Dec; 26(1):153-159. PubMed ID: 33491601
[No Abstract] [Full Text] [Related]
3. Functional characterization of two rare BCR-FGFR1
Barnes EJ; Leonard J; Medeiros BC; Druker BJ; Tognon CE
Cold Spring Harb Mol Case Stud; 2020 Apr; 6(2):. PubMed ID: 31980503
[TBL] [Abstract][Full Text] [Related]
4. The driver of malignancy in KG-1a leukemic cells, FGFR1OP2-FGFR1, encodes an HSP90 addicted oncoprotein.
Jin Y; Zhen Y; Haugsten EM; Wiedlocha A
Cell Signal; 2011 Nov; 23(11):1758-66. PubMed ID: 21745565
[TBL] [Abstract][Full Text] [Related]
5. Critical individual roles of the BCR and FGFR1 kinase domains in BCR-FGFR1-driven stem cell leukemia/lymphoma syndrome.
Chong Y; Liu Y; Lu S; Cai B; Qin H; Chang CS; Ren M; Cowell JK; Hu T
Int J Cancer; 2020 Apr; 146(8):2243-2254. PubMed ID: 31525277
[TBL] [Abstract][Full Text] [Related]
6. [8p11 myeloproliferative syndrome with CEP110-FGFR1 fusion in a patient].
Chao H; Chen S; Zhou M; Lu X; Zhang X; Pan J; Wu C; Zhang R
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Oct; 32(5):679-82. PubMed ID: 26418991
[TBL] [Abstract][Full Text] [Related]
7. A case of 8p11 myeloproliferative syndrome with BCR-FGFR1 gene fusion presenting with trilineage acute leukemia/lymphoma, successfully treated by cord blood transplantation.
Morishige S; Oku E; Takata Y; Kimura Y; Arakawa F; Seki R; Imamura R; Osaki K; Hashiguchi M; Yakushiji K; Mizuno S; Yoshimoto K; Nagafuji K; Ohshima K; Okamura T
Acta Haematol; 2013; 129(2):83-9. PubMed ID: 23171834
[TBL] [Abstract][Full Text] [Related]
8. Identification of a novel TFG-FGFR1 fusion gene in an acute myeloid leukaemia patient with t(3;8)(q12;p11).
Wang T; Wang Z; Zhang L; Wen L; Cai W; Yang X; Pan J; Ruan C; Wu D; Sun A; Chen S
Br J Haematol; 2020 Jan; 188(1):177-181. PubMed ID: 31802477
[No Abstract] [Full Text] [Related]
9. 8p11 myeloproliferative syndrome preceded by t(8;9)(p11;q33), CEP110/FGFR1 fusion transcript: morphologic, molecular, and cytogenetic characterization of myeloid neoplasms associated with eosinophilia and FGFR1 abnormality.
Park TS; Song J; Kim JS; Yang WI; Song S; Kim SJ; Suh B; Choi JR
Cancer Genet Cytogenet; 2008 Mar; 181(2):93-9. PubMed ID: 18295660
[TBL] [Abstract][Full Text] [Related]
10. Response to Tyrosine Kinase Inhibitors in Myeloproliferative Neoplasia with 8p11 Translocation and
Wehrli M; Oppliger Leibundgut E; Gattiker HH; Manz MG; Müller AM; Goede JS
Oncologist; 2017 Apr; 22(4):480-483. PubMed ID: 28242791
[TBL] [Abstract][Full Text] [Related]
11. Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL.
Fioretos T; Panagopoulos I; Lassen C; Swedin A; Billström R; Isaksson M; Strömbeck B; Olofsson T; Mitelman F; Johansson B
Genes Chromosomes Cancer; 2001 Dec; 32(4):302-10. PubMed ID: 11746971
[TBL] [Abstract][Full Text] [Related]
12. Molecular monitoring of 8p11 myeloproliferative syndrome in an infant.
Zhang WW; Habeebu S; Sheehan AM; Naeem R; Hernandez VS; Dreyer ZE; López-Terrada D
J Pediatr Hematol Oncol; 2009 Nov; 31(11):879-83. PubMed ID: 19829149
[TBL] [Abstract][Full Text] [Related]
13. Molecular identification of a TPR-FGFR1 fusion transcript in an adult with myeloproliferative neoplasm, T-lymphoblastic lymphoma, and a t(1;8)(q25;p11.2).
Kim SY; Kim JE; Park S; Kim HK
Cancer Genet; 2014 Jun; 207(6):258-62. PubMed ID: 25037443
[TBL] [Abstract][Full Text] [Related]
14. FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome.
Xiao S; Nalabolu SR; Aster JC; Ma J; Abruzzo L; Jaffe ES; Stone R; Weissman SM; Hudson TJ; Fletcher JA
Nat Genet; 1998 Jan; 18(1):84-7. PubMed ID: 9425908
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel partner gene, TPR, fused to FGFR1 in 8p11 myeloproliferative syndrome.
Li F; Zhai YP; Tang YM; Wang LP; Wan PJ
Genes Chromosomes Cancer; 2012 Sep; 51(9):890-7. PubMed ID: 22619110
[TBL] [Abstract][Full Text] [Related]
16. A biphenotypic transformation of 8p11 myeloproliferative syndrome with CEP1/FGFR1 fusion gene.
Yamamoto K; Kawano H; Nishikawa S; Yakushijin K; Okamura A; Matsui T
Eur J Haematol; 2006 Oct; 77(4):349-54. PubMed ID: 16879608
[TBL] [Abstract][Full Text] [Related]
17. Hematologic malignancies with PCM1-JAK2 gene fusion share characteristics with myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1.
Patterer V; Schnittger S; Kern W; Haferlach T; Haferlach C
Ann Hematol; 2013 Jun; 92(6):759-69. PubMed ID: 23400675
[TBL] [Abstract][Full Text] [Related]
18. Phosphotyrosine profiling identifies the KG-1 cell line as a model for the study of FGFR1 fusions in acute myeloid leukemia.
Gu TL; Goss VL; Reeves C; Popova L; Nardone J; Macneill J; Walters DK; Wang Y; Rush J; Comb MJ; Druker BJ; Polakiewicz RD
Blood; 2006 Dec; 108(13):4202-4. PubMed ID: 16946300
[TBL] [Abstract][Full Text] [Related]
19. FGFR1 fusion kinase regulation of MYC expression drives development of stem cell leukemia/lymphoma syndrome.
Hu T; Wu Q; Chong Y; Qin H; Poole CJ; van Riggelen J; Ren M; Cowell JK
Leukemia; 2018 Nov; 32(11):2363-2373. PubMed ID: 29720732
[TBL] [Abstract][Full Text] [Related]
20. Treatment of the myeloid/lymphoid neoplasm with FGFR1 rearrangement with FGFR1 inhibitor.
Verstovsek S; Subbiah V; Masarova L; Yin CC; Tang G; Manshouri T; Asatiani E; Daver NG
Ann Oncol; 2018 Aug; 29(8):1880-1882. PubMed ID: 29767670
[No Abstract] [Full Text] [Related]
[Next] [New Search]